Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Senti Biosciences ( (SNTI) ) has shared an update.
On January 31, 2025, the Consulting Agreement between Senti Biosciences, Inc. and Yvonne Li, the Interim Chief Financial Officer, expired. Subsequently, Ms. Li ceased to serve as the company’s principal financial and accounting officer. However, on February 5, 2025, a new consulting agreement was established, allowing Ms. Li to continue as a consultant to assist with the transition of her duties until March 31, 2025.
More about Senti Biosciences
YTD Price Performance: 17.06%
Average Trading Volume: 2,423,966
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $21.54M
For an in-depth examination of SNTI stock, go to TipRanks’ Stock Analysis page.
